Martin Müller

2.0k total citations · 1 hit paper
33 papers, 1.5k citations indexed

About

Martin Müller is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Martin Müller has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Physiology and 5 papers in Pharmacology. Recurrent topics in Martin Müller's work include Calcium signaling and nucleotide metabolism (6 papers), Cancer-related cognitive impairment studies (4 papers) and Autophagy in Disease and Therapy (4 papers). Martin Müller is often cited by papers focused on Calcium signaling and nucleotide metabolism (6 papers), Cancer-related cognitive impairment studies (4 papers) and Autophagy in Disease and Therapy (4 papers). Martin Müller collaborates with scholars based in Germany, Netherlands and United States. Martin Müller's co-authors include Sanne B. Schagen, Willem Boogerd, Frits S.A.M. van Dam, Sjoerd Rodenhuis, Elsken van der Wall, Karin Bartel, Angelika M. Vollmar, F.S.A.M. van Dam, Nelly Moerman and Hans Oosting and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Martin Müller

32 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy

1998 596 citations Frits S.A.M. van Dam, Willem Boogerd et al. JNCI Journal of the National Cancer Institute profile →

Peers

Countries citing papers authored by Martin Müller

Since Specialization

Citations

This map shows the geographic impact of Martin Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Müller more than expected).

Fields of papers citing papers by Martin Müller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Müller. The network helps show where Martin Müller may publish in the future.

Co-authorship network of co-authors of Martin Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Müller. A scholar is included among the top collaborators of Martin Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Müller. Martin Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting TPC2 sensitizes acute lymphoblastic leukemia cells to chemotherapeutics by impairing lysosomal function 2022 ·Cell Death and Disease ·(unknown), Martin Müller, Yu‐Kai Chao, Christian Grimm, Angelika M. Vollmar, Karin Bartel	15
2	Gene editing and synthetically accessible inhibitors reveal role for TPC2 in HCC cell proliferation and tumor growth 2021 ·Cell chemical biology ·Martin Müller, (unknown), Yu‐Kai Chao, (unknown), Ong Nam Phuong Nguyen, Aaron Gerwien, Nicole Urban, Christoph Müller, Florian Gegenfurtner, (unknown), (unknown), Cheng‐Chang Chen, Stefan Zahler, Martin Biel, Michael Schaefer, Christian Grimm, Franz Bracher, Angelika M. Vollmar, Karin Bartel	44
3	Synthesis, Biological Evaluation, and Structure–Activity Relationships of 4-Aminopiperidines as Novel Antifungal Agents Targeting Ergosterol Biosynthesis 2021 ·Molecules ·Jürgen Krauß, Christoph Müller, (unknown), (unknown), (unknown), Martin Müller, Karin Bartel, Ulrike Binder, Franz Bracher	9
4	Synthesis, biological evaluation and toxicity of novel tetrandrine analogues 2020 ·European Journal of Medicinal Chemistry ·(unknown), Martin Müller, (unknown), Angelika M. Vollmar, Karin Bartel, Franz Bracher	11
5	Targeting Lysosomes in Cancer as Promising Strategy to Overcome Chemoresistance—A Mini Review 2020 ·Frontiers in Oncology ·(unknown), Martin Müller, Angelika M. Vollmar, Karin Bartel	68
6	Metabolic implication of tigecycline as an efficacious second‐line treatment for sorafenib‐resistant hepatocellular carcinoma 2020 ·The FASEB Journal ·Martina Meßner, Sabine Schmitt, (unknown), Thomas Fröhlich, Martin Müller, Helmut Pein, (unknown), (unknown), Lars M. Koenig, (unknown), Andreas Koeberle, Georg J. Arnold, Simon Rothenfußer, Alexandra K. Kiemer, Alexander L. Gerbes, Hans Zischka, Angelika M. Vollmar, (unknown)	10
7	Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors 2019 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Johanna Senger, Daniel Herp, (unknown), Martin Marek, Martin Müller, Karin Bartel, T.B. Shaik, Nicholas J. Porter, Dina Robaa, David W. Christianson, Christophe Romier, Wolfgang Sippl, Manfred Jung, Franz Bracher	77
8	Determination of insecticidal Cry1Ab protein in soil collected in the final growing seasons of a nine-year field trial of Bt-maize MON810 2011 ·Transgenic Research ·(unknown), Vijay Paul, Heinrich Meyer, Martin Müller	37
9	Fate of Cry1Ab Protein in Agricultural Systems under Slurry Management of Cows Fed Genetically Modified Maize (Zea mays L.) MON810: A Quantitative Assessment 2011 ·Journal of Agricultural and Food Chemistry ·(unknown), Vijay Paul, Patrick Guertler, H. Spiekers, Aleš Tichopád, Heinrich Meyer, Martin Müller	11
10	Les nouveaux traitements du diabète de type 2 : quelle place pour les incrétines et le rimonabant par rapport aux précédents ? 2008 ·La Revue de Médecine Interne ·S. Halimi, (unknown), (unknown), Martin Müller	5
11	Effects of beta-hydroxy-beta-methylbuturate (HMB) supplementation on the body-composition and muscle power output of non-competitive sporting males 2007 ·UpSpace Institutional Repository (University of Pretoria) ·Martin Müller, P.J. Du Toit, Pieter Krüger	1
12	Effects of High-Dose and Conventional-Dose Adjuvant Chemotherapy on Long-Term Cognitive Sequelae in Patients with Breast Cancer: An Electrophysiologic Study 2006 ·Clinical Breast Cancer ·Baudewijntje P.C. Kreukels, Sanne B. Schagen, K. Richard Ridderinkhof, Willem Boogerd, Hans Hamburger, Martin Müller, Frits S.A.M. van Dam	63
13	A Splice Variant of the Human CCA-adding Enzyme with Modified Activity 2006 ·Journal of Molecular Biology ·Esther Lizano, Jens Schuster, Martin Müller, Janet Kelso, Mario Mörl	10
14	In vitro gene delivery by a novel human calcitonin (hCT)-derived carrier peptide 2003 ·Bioorganic & Medicinal Chemistry Letters ·Ulrike Krauss, Martin Müller, Michael Ståhl, Annette G. Beck‐Sickinger	35
15	Late effects of adjuvant chemotherapy on cognitive function:a follow-up study in breast cancer patients 2002 ·Annals of Oncology ·Sanne B. Schagen, Martin Müller, Willem Boogerd, (unknown), (unknown), Sjoerd Rodenhuis, F.S.A.M. van Dam	195
16	Role of Health-Related Quality of Life in Palliative Chemotherapy Treatment Decisions 2002 ·Journal of Clinical Oncology ·Symone Detmar, Martin Müller, Jan H. Schornagel, Lieke Wever, Neil K. Aaronson	33
17	Cognitive Dysfunction and Chemotherapy: Neuropsychological Findings in Perspective 2002 ·Clinical Breast Cancer ·Sanne B. Schagen, Martin Müller, Willem Boogerd, Frits S.A.M. van Dam	37
18	Differentiated assessment of metabolically active parts of fat-free mass in young adults. 2000 ·Aktuelle Ernährungsmedizin ·Martin Müller, (unknown), Anja Bosy‐Westphal, G. Brinkmann, Markus O. Heller	1
19	Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy breakdown → 1998 ·JNCI Journal of the National Cancer Institute ·Frits S.A.M. van Dam, Willem Boogerd, Sanne B. Schagen, Martin Müller, (unknown), Elsken van der Wall, Sjoerd Rodenhuis	596
20	Der Leukotriensignalweg – ein vielversprechender Ansatzpunkt für Inhibitoren in der Therapie entzündlicher Erkrankungen 1995 ·Pharmazie in unserer Zeit ·Martin Müller	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact